Ibu-Lysin (Ibuprofen Lysine)

Ibuprofen lysine, the active ingredient in Ibu-Lysin, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It relieves mild to moderate pain, reduces inflammation, and lowers fever in adult patients. GNH USA supplies Ibu-Lysin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibu-Lysin, an NSAID, is employed to manage pain and inflammation across several common conditions.

Headache: provides rapid analgesic relief. Musculoskeletal pain: reduces pain and swelling associated with strains, sprains and arthritis. Fever: lowers elevated body temperature in acute febrile states.

Adverse reactions may occur with ibuprofen lysine use.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, abdominal pain. - Headache: mild and transient. - Dizziness: occasional light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Severe gastrointestinal bleeding or ulceration. - Allergic reactions: rash, angioedema, anaphylaxis. - Renal impairment: reduced kidney function, especially in dehydrated patients. - Hepatotoxicity: elevated liver enzymes or liver injury.

Before prescribing Ibu-Lysin, consider the following safety measures. - Assess renal function: avoid in severe renal impairment. - Monitor gastrointestinal risk: use with food in patients with ulcer history. - Avoid in third‑trimester pregnancy: risk of fetal complications. - Use caution with anticoagulants: increased bleeding tendency. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ibuprofen lysine can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased hemorrhage potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible reduction in renal function. - Diuretics: risk of renal impairment when combined. - Lithium: potential elevation of serum lithium levels.